Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

A Jordanian family with Clouston syndrome has a common GJB6 gene mutation.

The document concludes that the girl's hairlessness is likely inherited from her parents.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Eyelash curvature is linked to the thickness of the cuticle layer at the root.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Bimatoprost can help grow eyebrow hair.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

A young woman developed facial bumps before hair loss, which is unusual for her condition.

Ringworm around the eyes often gets misdiagnosed, leading to eyelash loss, but antifungal treatment can improve the condition.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Cetuximab can cause eyelash growth, which is rare but manageable.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

The document's conclusion cannot be provided because the content is not available.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

Latanoprost eye drops caused excessive cheek hair growth and eyelash whitening in a woman.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Travoprost can help eyelash growth but may cause darkening around the eyes.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.